跳至主要内容
临床试验/JPRN-UMIN000021336
JPRN-UMIN000021336已完成1 期

Phase 1 study to evaluate the safety and efficacy of jyuzentaihoto in infantile anal fistula - Safety and efficacy of jyuzentaihoto in infantile anal fistula

Kanazawa University0 个研究点目标入组 20 人开始时间: 2016年3月4日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1years-old 至 2years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Any of the following: currently receiving a drug therapy, currently having chronic diseases such as heart, lung, kidney, gastrointestinal, and inflammatory diseases, suffering from invasive cancer within five years, suffering from non-invasive cancer within a year, and having taken Kampo medicine within 2 weeks.

研究者

相似试验